ArticleScientific reports2018
Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.
Abstract read
In one paragraph
Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.The New England journal of medicine · 2023Trial
- Article
- Epidemic forecast and preparedness for explosive-cerebrospinal meningitis outbreak in Nigeria using the preventive vaccination strategy.African journal of laboratory medicine · 2023Review
- Evaluation of Dried Blood and Cerebrospinal Fluid Filter Paper Spots for Storing and Transporting Clinical Material for the Molecular Diagnosis of Invasive Meningococcal Disease.International journal of molecular sciences · 2022Article
- Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review.Infectious diseases and therapy · 2022Review
- Neisseria meningitidis Serogroup C Clonal Complex 10217 Outbreak in West Kpendjal Prefecture, Togo 2019.Microbiology spectrum · 2022Article
- Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.Infectious diseases and therapy · 2021Review
- An overview of bacterial meningitis epidemics in Africa from 1928 to 2018 with a focus on epidemics "outside-the-belt".BMC infectious diseases · 2021Review
- Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.The Journal of infectious diseases · 2021Article
- Etiology of Pediatric Meningitis in West Africa Using Molecular Methods in the Era of Conjugate Vaccines against Pneumococcus, Meningococcus, andThe American journal of tropical medicine and hygiene · 2020Article
- Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.The Journal of infectious diseases · 2019Review
- Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.The Journal of infectious diseases · 2019Article
- Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Article
- Meningitis Vaccine Delivery Strategies and Their Health Impact in Africa: A Scoping Review to Inform the Introduction of New Vaccines.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors.
Brenda A Kwambana-AdamsWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Rahab C AmazaNigeria Center for Disease Control, Abuja, Nigeria.
Catherine OkoiWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Murtala RabiuAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.ORCID 0000-0002-9823-8724
Archibald WorwuiWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Ebenezer Foster-NyarkoWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Bernard EbrukeWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Abdul K SesayWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Madikay SenghoreWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
Abdullahi S UmarZamfara State Ministry of Health, Gusau, Nigeria.
Rabi UsmanZamfara State Ministry of Health, Gusau, Nigeria.
Adamu AtikuZamfara State Ministry of Health, Gusau, Nigeria.
Garba AbdullahiNigeria Center for Disease Control, Abuja, Nigeria.
Yahaya BuhariAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
Rabiu SaniAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
Husaini U BakoAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
Bashir AbdullahiAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
Alliyu I YarimaAhmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
Badaru SikiruNigeria Center for Disease Control, Abuja, Nigeria.
Aderinola Olaolu MosesNigeria Center for Disease Control, Abuja, Nigeria.
Michael O PopoolaNigeria Center for Disease Control, Abuja, Nigeria.
Eme EkengNigeria Center for Disease Control, Abuja, Nigeria.
Adebola OlayinkaNigeria Center for Disease Control, Abuja, Nigeria.
Nwando MbaNigeria Center for Disease Control, Abuja, Nigeria.
Adamu KankiaWorld Health Organization, Country Office Nigeria, Abuja, Nigeria.
Ibrahim N MamaduWorld Health Organization, Country Office Nigeria, Abuja, Nigeria.
Ifeanyi OkudoWorld Health Organization, Country Office Nigeria, Abuja, Nigeria.
Mary StephenWorld Health Organization, Country Office Nigeria, Abuja, Nigeria.
Olivier RonveauxWorld Health Organization, Geneva, Switzerland.
Jason BusuttilUK-Public Health Rapid Support Team, Public Health England, Salisbury, UK.
Jason M MwendaWorld Health Organization, Regional office for Africa, Brazzaville, Congo.
Mohammed AbdulazizAfrica Centres for Diseases Control and Prevention, Addis Ababa, Ethiopia.
Sulaiman A GummiZamfara State Ministry of Health, Gusau, Nigeria.
Adebayo AdedejiNigeria Center for Disease Control, Abuja, Nigeria.
Andre BitaWorld Health Organization Inter-Country Support Teams for West Africa, Ouagadougou, Burkina Faso.
Linda OmarWorld Health Organization, Regional office for Africa, Brazzaville, Congo.
Mamoudou Harouna DjingareyWorld Health Organization, Regional office for Africa, Brazzaville, Congo.
Wondimagegnehu AlemuWorld Health Organization, Country Office Nigeria, Abuja, Nigeria.
Umberto D'AlessandroDisease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.ORCID 0000-0001-6341-5009
Chikwe IhekweazuNigeria Center for Disease Control, Abuja, Nigeria.
Martin AntonioWorld Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia. mantonio@mrc.gm.
Funding
Medical Research Council MC_UP_A900_1119
Abstract
After the successful roll out of MenAfriVac, Nigeria has experienced sequential meningitis outbreaks attributed to meningococcus serogroup C (NmC). Zamfara State in North-western Nigeria recently was at the epicentre of the largest NmC outbreak in the 21
Indexed as
AdolescentAdultChildChild, PreschoolDisease OutbreaksFemaleHumansIncidenceInfantMaleMeningitis, MeningococcalMeningococcal VaccinesNeisseria meningitidis, Serogroup CNigeriaSerogroupStreptococcus pneumoniaeMenAfriVacMeningococcal Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.